BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

487 related articles for article (PubMed ID: 11240405)

  • 1. [Doping: effectiveness, consequences, prevention].
    Guezennec CY
    Ann Endocrinol (Paris); 2001 Feb; 62(1 Pt 1):33-41. PubMed ID: 11240405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A race to the starting line.
    Vogel G
    Science; 2004 Jul; 305(5684):632-5. PubMed ID: 15286358
    [No Abstract]   [Full Text] [Related]  

  • 3. [Doping and urologic tumors].
    Pinto F; Sacco E; Volpe A; Gardi M; Totaro A; Calarco A; Racioppi M; Gulino G; D'Addessi A; Bassi PF
    Urologia; 2010; 77(2):92-9. PubMed ID: 20890867
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Analytical strategy for detecting doping agents in hair.
    Thieme D; Grosse J; Sachs H; Mueller RK
    Forensic Sci Int; 2000 Jan; 107(1-3):335-45. PubMed ID: 10689585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Doctors belonging to the Senegalese Association of Sport Medicine and doping in sports: survey on knowledge and attitudes].
    Dièye AM; Diallo B; Fall A; Ndiaye M; Cissè F; Faye B
    Sante; 2005; 15(3):167-70. PubMed ID: 16207578
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Doping--also a problem in general practice?].
    Dickhuth HH; Berg A; Baumstark M; Rokitzki L; Huonker M; Keul J
    Fortschr Med; 1989 Sep; 107(28):585-8. PubMed ID: 2613151
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Introduction to the application of capillary gas chromatography of performance-enhancing drugs in doping control.
    Müller RK; Grosse J; Thieme D; Lang R; Teske J; Trauer H
    J Chromatogr A; 1999 May; 843(1-2):275-85. PubMed ID: 10399856
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ESC study group of sports cardiology position paper on adverse cardiovascular effects of doping in athletes.
    Deligiannis A; Björnstad H; Carre F; Heidbüchel H; Kouidi E; Panhuyzen-Goedkoop NM; Pigozzi F; Schänzer W; Vanhees L;
    Eur J Cardiovasc Prev Rehabil; 2006 Oct; 13(5):687-94. PubMed ID: 17001206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Practical experience with the implementation of an athlete's biological profile in athletics, cycling, football and swimming.
    Zorzoli M; Pipe A; Garnier PY; Vouillamoz M; Dvorak J
    Br J Sports Med; 2014 May; 48(10):862-6. PubMed ID: 24648438
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Doping with growth hormone/IGF-1, anabolic steroids or erythropoietin: is there a cancer risk?
    Tentori L; Graziani G
    Pharmacol Res; 2007 May; 55(5):359-69. PubMed ID: 17349798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ultra high performance liquid chromatography tandem mass spectrometry determination and profiling of prohibited steroids in human biological matrices. A review.
    Gosetti F; Mazzucco E; Gennaro MC; Marengo E
    J Chromatogr B Analyt Technol Biomed Life Sci; 2013 May; 927():22-36. PubMed ID: 23317577
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Doping in sport: effects, harm and misconceptions.
    Birzniece V
    Intern Med J; 2015 Mar; 45(3):239-48. PubMed ID: 25369881
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ergogenic drugs in sports.
    Knopp WD; Wang TW; Bach BR
    Clin Sports Med; 1997 Jul; 16(3):375-92. PubMed ID: 9209817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Blood doping: 2].
    Cristani A; Boldrini E; Amateis E; Arioli D
    Recenti Prog Med; 2005 Jan; 96(1):1-3. PubMed ID: 15789630
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Annual banned-substance review: Analytical approaches in human sports drug testing.
    Thevis M; Kuuranne T; Geyer H
    Drug Test Anal; 2019 Jan; 11(1):8-26. PubMed ID: 30488582
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Current Status of Doping in Japan Based on Japan Anti-Doping Disciplinary Panels of the Japan Anti-Doping Agency (JADA): A Suggestion on Anti-Doping Activities by Pharmacists in Japan].
    Imanishi T; Kawabata T; Takayama A
    Yakugaku Zasshi; 2017; 137(7):883-891. PubMed ID: 28674304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Medication, athletes and doping regulations].
    Hartgens F
    Ned Tijdschr Geneeskd; 2008 Aug; 152(33):1844-8. PubMed ID: 18783164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sports drug testing using complementary matrices: Advantages and limitations.
    Thevis M; Geyer H; Tretzel L; Schänzer W
    J Pharm Biomed Anal; 2016 Oct; 130():220-230. PubMed ID: 27040951
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Medical aspects of drug use in the gym.
    Drug Ther Bull; 2004 Jan; 42(1):1-5. PubMed ID: 14768297
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Are drugs winning the games?
    Sullivan R; Song S
    Time; 2000 Sep; 156(11):90-2. PubMed ID: 11067230
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 25.